Vardenafil increases intracellular accumulation of the most prevalent mutant CFTR in human bronchial epithelial cells
Open Access
- 1 January 2020
- journal article
- research article
- Published by The Company of Biologists in Biology Open
- Vol. 9 (8)
Abstract
Cystic fibrosis (CF) is a genetic disease characterized by progressive lung and chronic digestive manifestations. We have shown that therapeutic doses of vardenafil, a phosphodiesterase type 5 (PDE5) inhibitor, corrects CF Transmembrane conductance Regulator (CFTR)-dependent chloride transport in respiratory and intestinal tissues of F508del homozygous mice. Here, we studied the effect of vardenafil on CFTR in 16HBE14o– and CFBE41o− cell lines. First, the expression levels of PDE5 mRNA in these cell lines were monitored. The two cell lines were exposed to different drugs (dimethyl sulfoxide, 8-Br-cGMP, forskolin or vardenafil). The cAMP and cGMP intracellular concentrations were measured. Finally, we localised the CFTR by immunolabelling. PDE5 was similarly expressed in both wild-type and in CF cells. A fast and transient rise in cGMP intracellular contents followed treatment with vardenafil, confirming its PDE5 inhibitory effect. We showed that vardenafil promoted both the early steps of the cellular processing and the trafficking of F508del without fully addressing the protein to the plasma membrane. The effect was not reproduced by the brominated cGMP analogue and it was not prevented by the combination of a protein kinase G (PKG) inhibitor and vardenafil. These findings support the view that vardenafil partially rescues F508del through cGMP/PKG-independent mechanisms.Keywords
Funding Information
- Fund for Research Training in Industry and Agriculture
- Fund of Scientific Research – Fonds National de la Recherche Scientifique (FSR-FNRS)
- Fonds Spéciaux de Recherche
- European Commission
- Fonds de la Recherche Scientifique Médicale (FRSM), Fonds Spéciaux de Recherche
- Foundation St Luc
- Belgian Cystic Fibrosis Foundation
This publication has 67 references indexed in Scilit:
- Correction of Chloride Transport and Mislocalization of CFTR Protein by Vardenafil in the Gastrointestinal Tract of Cystic Fibrosis MicePLOS ONE, 2013
- Dysregulated Proinflammatory and Fibrogenic Phenotype of Fibroblasts in Cystic FibrosisPLOS ONE, 2013
- Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809Proceedings of the National Academy of Sciences, 2011
- The Phosphodiesterase-5 Inhibitor Vardenafil Is a Potent Inhibitor of ABCB1/P-Glycoprotein TransporterPLOS ONE, 2011
- The Cystic Fibrosis-causing Mutation ΔF508 Affects Multiple Steps in Cystic Fibrosis Transmembrane Conductance Regulator BiogenesisJournal of Biological Chemistry, 2010
- Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770Proceedings of the National Academy of Sciences, 2009
- Cl Transport in Complemented CF Bronchial Epithelial Cells Correlates with CFTR mRNA Expression LevelsCellular Physiology and Biochemistry, 2008
- Towards an in vitro model of cystic fibrosis small airway epithelium: characterisation of the human bronchial epithelial cell line CFBE41o-Cell and tissue research, 2005
- The role of epithelial P2Y2 and P2Y4 receptors in the regulation of intestinal chloride secretionBritish Journal of Pharmacology, 2005
- VASODILATIONThe Lancet, 1993